Study on the Characteristics and Cellular Origins of the Sebaceous Gland

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500114709

Enrollment

Unknown

Registered

2025-12-16

Start date

2025-12-22

Completion date

Unknown

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Interventions

Rosiglitazone treatment group:Topical application of an ointment containing rosiglitazone

Vehicle control group:Topical application of an ointment containing the vehicle solvent

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Recruit volunteers with atopic dermatitis in symmetrical locations. 2.Dry skin induced atopic dermatitis.

Exclusion criteria

Exclusion criteria: 1.Areas with atopic dermatitis should not have skin infections or very severe skin lesions.

Design outcomes

Primary

Measure	Time frame
The total area affected by atopic dermatitis. The size, number, appearance of rashes, and the area of skin lesions. SCORAD score.;	—

Secondary

Measure	Time frame
Sebum on skin surface;	—

Countries

China

Contacts

Public ContactZhuzhen Zhang

WUHAN UNIVERSITY

zhuzhenzhang@whu.edu.cn+86 27 8741 6322

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026